The Conversation (0)
- WORLD EDITIONAustraliaNorth AmericaWorld
December 09, 2024
Zero Candida (the "Company" or "ZC") (TSXV: ZCT), an Israeli FemTech medical device start-up, is pleased to announce the Company has received a final patent from South Africa PCT patent PCT-IL 2023050243 in South Africa. In addition, the company is actively pursuing a global patent portfolio with applications filed worldwide including in the United States, Brazil, and Europe.
Zero-Candida T technologies, Inc. (ZCT) is FemTech developing an AI smart tampon-like device based on a therapeutic light source with a selected wave-length and intensity that can treat the Candida fungus successfully of 99.999% an POC overnight. Vulvo-Vaginal Candidiasis ("VVC") affects about 75% of women globally, and ZCT's device is game changer that has the potential to change the treatment of women and the FemTech industry in the world. The first of its kind of technology using a controlled "Blue Light," destroys the vagina fungus at record speed and without side effects. The treatment is safe and administered using the tampon-like medical device which, according to medical experts, is an optimal solution for removing the fungus altogether and preventing the recurrence of the disease.
Zero Candida is working on creating technology that enables hybrid medicine services to be provided by gynecologists to populations that until now, have had no access to treatment, including among others, those in developing countries. The ZCT device collects and transmits treatment data to the attending physician in real time, for assessment, treatment personalization, and monitoring. Seamless data transfer through a Wi-Fi chip and VoIP, allows for the convenience of remote care and treatment consulting. Another significant advantage of ZCT's device is that the treatment is free from side effects, supporting the growing demand from women to improve their health without the use of chemicals.
Eli Ben Haroosh, Founder & CEO: "Zero Candida is a groundbreaking and game-changing company in the world of women's medicine, accordingly we will hold patents in every possible continent in the world. The company's doctors' team is one of the best in the world in the field of women's health, together with patents around the world, will give the company business strength".
Dr. Asher Holzer, CTO & Director: "As the company's chief scientist, I find it of utmost importance to obtain a patent for the company's inventions and product development. Zero Candida is a world leader in technology that includes hybrid medicine, and technology-based diagnostics".
About Zero Candida:
ZC is a Public FemTech company incorporated under the corporate laws of the State of Israel. ZC is developing an AI smart tampon-like device based on a therapeutic light source with a selected wave-length and intensity that can treat the Candida fungus successfully of 99.999% an POC. Vulvo-Vaginal Candidiasis ("VVC") affects about 75% of women globally, each year 138 million women are affected, and 492 million over their lifetime. Recurrent VVC (4 or more episodes per year) is increasingly documented to become drug resistant to existing treatments and constitutes up to 10% of the cases of VVC. Existing treatments are unable to overcome the high rate of recurrence, since the root cause of the condition is poorly understood and addressed.
ZC has signed pre-clinical agreements with hospitals in Israel and Europe and has successfully completed a safety trial for the use of their pre-clinical device in large animals (sheep). The company is advancing the development of their final product for human use in preparation for a clinical trial that will take place in June 2025.
Zero Candida's device will bring the field of gynecology into the 21st century with hybrid medicine and technology-based diagnostics. At the same time as developing the treatment procedure, Zero Candida is creating technology to enable hybrid medicine services to be offered by gynecologists to populations that until now, received no treatment at all, including, among others, in the developing countries.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Forward-Looking Statements
This news release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, are forward-looking statements. The Company provides no assurance that forward-looking statements and information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements or information. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company does not undertake to update any forward-looking statements, other than as required by law. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Zero Candida. Readers are cautioned not to place undue reliance on forward-looking statements.
Contact:
Victoria Gamble
E: Victoria@zero-candida.com
P: (647) 874 - 3767
Eli Ben Haroosh, CEO & Founder
E: info@zero-candida.com
Website: www.Zero-Candida.com
LinkedIn: @Zero-Candida
ZCT:CA
16 December 2024
Zero Candida Technologies
Investor Insight
Zero Candida’s innovative technology poised to be a game-changer for women’s health presents a compelling investment case to gain exposure to the rapidly expanding fem-tech market.
Overview
Zero Candida (TSXV:ZCT) is a fem-tech pioneer, combining advanced artificial intelligence with non-drug diagnostics and personalized treatment modalities in a single device. Zero Candida offers an innovative, first-of-its-kind solution to the diagnosis and treatment of Candidiasis, a fungal infection causing irritation, discharge and intense itchiness of the vagina and the vulva.
Founded by a team of seasoned entrepreneurs and healthcare experts, Zero Candida addresses the significant unmet needs of the women’s health market. The device offers precision therapy by eliminating fungal infections with over 99.99 percent effectiveness in just three hours, a revolutionary improvement over existing treatments.
The fem-tech market is rapidly expanding, projected to reach nearly US$30 billion by 2032. Candidiasis represents a multi-billion-dollar market, with recurrence rates creating sustained demand for effective solutions. Zero Candida’s technology provides a scalable and adaptable platform that addresses both immediate treatment needs and long-term prevention.
Zero Candida is on track to complete clinical trials and file for FDA approval in 2025. The company is listed on the TSXV and the Frankfurt Stock Exchange, expanding its market presence in North America and Europe. With its innovative technology, Zero Candida is well-positioned to set new standards in women’s health management.
Get access to more exclusive Medical Device Investing Stock profiles here
Keep reading...Show less
Pioneering a technology-driven, innovative solution for the non-drug treatment of Candidiasis.
18 December 2024
Zero Candida Technologies:Pioneering Technology-driven, Innovative Solution for Non-drug Treatment of Candidiasis
Founded by a team of seasoned entrepreneurs and healthcare experts, Zero Candida (TSXV:ZCT) is a fem-tech pioneer, combining advanced artificial intelligence with non-drug diagnostics and personalized treatment modalities in a single device. The company developed an innovative, first-of-its-kind solution to the diagnosis and treatment of Candidiasis, a fungal infection causing irritation, discharge and intense itchiness of the vagina and the vulva. The device offers precision therapy by eliminating fungal infections with over 99.99 percent effectiveness in just three hours, a revolutionary improvement over existing treatments.
Zero Candida is on track to complete clinical trials and file for FDA approval in 2024 with its innovative technology.
Zero Candida's SMART vaginal diagnostic device utilizes blue light therapy to treat this widespread condition without drugs. This non-drug therapy addresses key issues associated with conventional antifungal medications, including reduced risk of drug resistance, minimized side effects, and potential for faster symptom relief
Company Highlights
- Zero Candida Technologies is a fem-tech company focused on developing a SMART diagnostic and therapeutic device aimed at eliminating vaginal candidiasis (commonly known as yeast infection), a condition that affects three out four women globally.
- Candidiasis a fungal infection causing irritation, discharge and intense itchiness of the vagina and the vulva. In several cases, the current treatment for Candidiasis has been ineffective.
- Zero Candida has completed proof-of-concept studies, and demonstrated near-complete fungal eradication with over 99.99 percent effectiveness in just three hours.
- Founded by a team of experienced entrepreneurs and healthcare experts, the company is addressing the significant unmet needs of the women’s health market.
- The fem-tech segment of the med tech market is expected to grow at a CAGR of 18.2 percent and is estimated to reach nearly US$30 billion by 2032. North America dominated the global fem-tech market with a share of 52.91 percent in 2023.
- The company has already patented this technology in South Africa, while additional filings for patent application in the US and EU are underway.
This Zero Candida profile is part of a paid investor education campaign.*
Click here to connect with Zero Candida (TSXV:CZT) to receive an Investor Presentation
Keep reading...Show less
16 September
NVIDIA Facing Weak Demand for New Chip as Chinese Firms Turn to Homegrown Silicon
NVIDIA's (NASDAQ:NVDA) new RTX6000D chip, built to comply with US export curbs, is seeing little demand from major Chinese firms, sources familiar with the matter told Reuters this week.
Tests showed it lags the banned RTX5090, which remains widely available through gray market channels at less than half the RTX6000D’s price of roughly 50,000 yuan (around US$7,000).
NVIDIA currently faces a balancing dilemma in China, where the US has barred exports of its most advanced processors to limit Beijing’s artificial intelligence (AI) progress, forcing the company to design downgraded models.
While sell-side analysts had forecast robust demand, including projections of 1.5 million to 2 million RTX6000Ds produced in the second half of 2025, some of China’s biggest technology buyers appear unconvinced.
Instead, tech giants Alibaba (NYSE:BABA), Tencent Holdings (OTC Pink:TCEHY,HKEX:0770) and ByteDance are waiting for clarity on shipments of NVIDIA's H20, the most powerful AI processor the US has permitted the firm to sell in China.
The US reinstated licenses for the H20 in July, but deliveries have not restarted. Companies are also watching closely to see whether NVIDIA's B30A, a stronger model still under review in Washington, will win approval.
Chinese tech firms turn to local alternatives
At the same time, NVIDIA is facing a longer-term challenge: leading Chinese firms are beginning to lean more heavily on their own silicon. Alibaba and Baidu (NASDAQ:BIDU) have started using internally designed chips to train AI models, according to the Information, marking a shift away from exclusive reliance on NVIDIA hardware.
Alibaba has deployed its chips for smaller AI models since early this year, while Baidu is experimenting with training new versions of its Ernie AI model using its Kunlun P800 processor.
According to the report, three employees who have worked with Alibaba’s chip said that its performance is now competitive with NVIDIA's H20, a sign of the rapid improvement in China’s homegrown designs.
Neither Alibaba nor Baidu responded to requests for comment from Reuters.
In response to the report, NVIDIA said: “The competition has undeniably arrived ... We’ll continue to work to earn the trust and support of mainstream developers everywhere.”
Although most companies still rely on NVIDIA chips for their most advanced systems, Beijing has made clear that it wants its local firms to reduce dependence on foreign suppliers by adopting domestic alternatives where feasible.
Regulatory pressure from Beijing
Compounding NVIDIA's difficulties, China’s market regulator has accused the US chipmaker of violating anti-monopoly laws. The watchdog did not specify what conduct was under investigation, but said it will continue its probe.
NVIDIA refuted the allegations, stating that it has complied with Chinese law “in all respects” and pledging to cooperate with “all relevant government agencies.”
The company has been under scrutiny in China since December, when regulators launched an initial inquiry seen as a countermeasure in the wider semiconductor standoff with Washington.
NVIDIA CEO Jensen Huang said late last month that discussions with the White House over licensing a less advanced version of its next-generation chip for China “will take time.”
Separately, the company has reportedly struck a deal with US President Donald Trump to exchange 15 percent of its China sales revenue from H20 chips in return for export approvals.
Don't forget to follow us @INN_Technology for real-time news updates!
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
Keep reading...Show less
12 September
Syntheia Announces Closing of Private Placement
Syntheia Corp. (CSE: SYAI) (syntheia.ai) (the "Company"), is pleased to announce that further to its press releases dated July 23, 2025, and September 2, 2025 the Company has closed the second tranche of its non-brokered private placement financing for gross proceeds of $709,677.48 through the issuance of 5,913,979 units (each, a "Unit") at a price of $0.12 per Unit (the "Offering").
Each Unit was comprised of one common share in the capital of the Company (each, a "Common Share") and one Common Share purchase warrant (each, a "Warrant"). Each Warrant is exercisable to acquire one Common Share at a price of $0.16 until September 2, 2030 (the "Expiry Date"), subject to an accelerated expiry in the event the volume weighted average trading price of the Common Shares exceeds $0.20 for 20 consecutive trading days, the Company may, within 10 business days of the occurrence of such event, deliver a notice to the holders of the Warrants accelerating their Expiry Date to a date that is not less than 30 days following the date of such notice and the issuance of a press release by the Company announcing the acceleration notice (the "Accelerated Exercise Period"). Any unexercised Warrants shall automatically expire at the end of the Accelerated Exercise Period.
In connection with the Offering, the Company paid: (i) a cash commission of $22,880.00; and (ii) 190,667 finder's warrants (each, a "Finder's Warrant") to certain finders (the "Finders"). Each Finder's Warrant is exercisable to purchase one additional common share (each, a "Finder's Share") at a price of $0.16 per Finder's Share. The Finder's Warrants have the same terms as the Warrants issued under the Offering.
An additional tranche of the Offering is expected to follow shortly. Gross proceeds raised from the Offering will be used for working capital, general corporate purposes, and to satisfy part of the purchase price for the asset acquisition as previously announced on July 4, 2025. All securities issued in connection with the Offering will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.
The Offering constituted a related party transaction within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101") as certain insiders of the Company subscribed for an aggregate of 230,000 Units pursuant to the Offering. The Company is relying on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(b) and 5.7(1)(a) of MI 61-101, as the Company is not listed on a specified market and the fair market value of the participation in the Offering by insiders does not exceed 25% of the market capitalization of the Company in accordance with MI 61-101. The Company did not file a material change report in respect of the related party transaction at least 21 days before the closing of the of the Offering, which the Company deems reasonable in the circumstances in order to complete the Offering in an expeditious manner.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons as defined under applicable United States securities laws unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
About Syntheia
Syntheia Corp. is an early-stage artificial intelligence technology company, channeling its efforts into refining and expanding its proprietary, conversational AI-based platform (the "Syntheia AI Platform"). The Syntheia AI Platform represents the integration of natural language processing ("NLP") technology, enabling it to not only understand but also respond to human language with accuracy. The Syntheia AI Platform, a generative, AI-powered algorithm equipped with a human-like voice, boasts self-learning capabilities derived from NLP methodologies.
Currently in beta testing, the Syntheia AI Platform is crafted to offer a suite of automated solutions, particularly for retail-focused businesses where customer interaction and service are key to operations. At the heart of the Syntheia AI Platform is its use of AI to emulate human cognitive processes, combined with a sophisticated large language model, which is integral for interpreting and generating human-like language responses.
For further information, please contact:
Tony Di Benedetto
Chief Executive Officer
Tel: (416) 791-9399
Cautionary Statement
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.
This news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.
The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Click here to connect with Syntheia Corp. (CSE: SYAI) to receive an Investor Presentation
Keep reading...Show less
09 September
Nebius Shares Soar on US$17.4 Billion Microsoft AI Deal
Nebius Group (NASDAQ:NBIS) surged on Tuesday (September 9) after announcing a multibillion-dollar deal with Microsoft (NASDAQ:MSFT) to provide dedicated artificial intelligence (AI) infrastructure.
Valued at US$17.4 billion over five years and expandable to US$19.4 billion if demand increases, the arrangement will see Nebius supply Microsoft with computing capacity from a new data center under construction in Vineland, New Jersey.
The news sent Nebius shares up 43.3 percent to US$91.75, their highest level on record.
For Nebius, a spinout from Russian tech giant Yandex that has grown into a full-stack AI infrastructure provider, the agreement represents a milestone in its long-term expansion strategy.
“Nebius’s core AI cloud business, serving customers from AI startups to enterprises, is performing exceptionally well,” said Arkady Volozh, the company's founder and CEO, in a statement. “We have also said that, in addition to our core business, we expect to secure significant long-term committed contracts with leading AI labs and big tech companies. I’m happy to announce the first of these contracts, and I believe there are more to come."
Microsoft’s mounting need for external infrastructure comes as it outpaces its in-house capacity amid a broader surge in demand for generative AI services. The company, already a key backer of OpenAI, has struck similar agreements with CoreWeave (NASDAQ:CRWV) to secure high-performance computing resources.
By turning to firms like Nebius, Microsoft is looking to bridge shortages of the advanced graphics processing units (GPUs) needed to run large AI models. The company's Vineland facility, part of a wave of new greenfield projects, will provide the dedicated GPU clusters that Microsoft requires to scale its AI services. The arrangement will allow Microsoft to lock in additional computing power, while providing Nebius with long-term revenue visibility.
Beyond its cloud business, Nebius also operates or invests in related ventures, including autonomous driving technology developer Avride, edtech platform TripleTen and database company ClickHouse.
As mentioned, the scale of Nebius' Microsoft contract has immediately reshaped investor sentiment. Nebius shares, which have already more than doubled this year, gained nearly half their value in a single session.
The rally spilled over to CoreWeave, which has its own multibillion-dollar contract with Microsoft and OpenAI.
Analysts suggest that the Microsoft deal positions Nebius to attract additional marquee customers, including other hyperscalers and frontier AI labs, as the company ramps up its global footprint.
Currently, there are expectations that the company, once considered a niche spinoff, could become one of the central players in supplying infrastructure for the AI boom.
Deliveries to Microsoft are expected to begin later this year.
Don’t forget to follow us @INN_Technology for real-time news updates!
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
Keep reading...Show less
08 September
OpenAI Taps Broadcom to Build Custom AI Chips in Face of GPU Supply Concerns
OpenAI, the company behind ChatGPT, is reportedly set to begin large-scale production of its own artificial intelligence (AI) chips through a partnership with Broadcom (NASDAQ:AVGO).
Experts in the space see the move as a bid to cut reliance on chip giant NVIDIA (NASDAQ:NVDA) and ease the global shortage of processors driving platforms like ChatGPT.
The news came after Broadcom CEO Hock Tan told analysts in a September 4 call that the company had secured a fourth major customer that has committed to a US$10 billion order.
Tan said the deal would bring “immediate and fairly substantial demand” beginning next year. Although he did not name the customer, sources have since identified it as OpenAI. Both companies have declined to comment publicly.
OpenAI has long relied on NVIDIA's graphics processing units (GPUs) for its AI needs, but securing enough GPUs has become increasingly difficult as demand for large-scale computing surges.
OpenAI CEO Sam Altman has been blunt about the challenge. In February, he wrote on X: “It is a giant, expensive model. We really wanted to launch it to plus and pro at the same time, but we’ve been growing a lot and are out of GPUs.”
Altman added at the time that OpenAI was preparing to add “tens of thousands of GPUs next week … (hundreds of thousands coming soon, and I’m pretty sure y’all will use every one we can rack up).”
However, shortfalls have slowed the rollout of new models, including GPT-4.5 earlier this year, and have pushed OpenAI to explore alternatives. The Broadcom deal marks its clearest step yet in building in-house hardware.
Broadcom has been developing custom processors it calls XPUs, or accelerated processing units, which are designed for specific high-intensity applications such as AI training. A person close to the project told the Financial Times that the new chips are intended to serve OpenAI internally rather than be sold to outside customers.
The prospect of custom silicon entering the AI infrastructure market has lifted Broadcom, which has climbed more than 30 percent this year. After Tan’s announcement, shares rose nearly 11 percent in New York trading.
For OpenAI, the investment is both a hedge and a necessity. The company has been racing to scale up computing capacity as businesses and consumers adopt ChatGPT in greater numbers. Last month, Altman said OpenAI planned to double its compute fleet “over the next 5 months” to meet demand from its newest model, GPT-5.
Alongside the Broadcom chips, OpenAI has made other major moves as well: it has signed a multibillion-dollar data center contract with Oracle (NYSE:ORCL) in July, struck a smaller cloud deal with Alphabet's (NASDAQ:GOOGL) Google in June and announced its own data center initiative called Stargate at the beginning of the year.
The deal with Broadcom also comes as Altman has been working to frame OpenAI not only as a leader in cutting-edge research, but also as a driver of economic opportunity. In a message earlier this month, he said that while AI will be disruptive, it also has the potential to “unlock more opportunities for more people than any technology in history.”
He pointed to initiatives such as the OpenAI Academy and a new jobs platform designed to help workers and companies connect over AI skills, with the goal of certifying 10 million Americans in AI fluency by 2030.
Don’t forget to follow us @INN_Technology for real-time news updates!
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
Keep reading...Show less
04 September
10 Generative AI Stocks to Watch as ChatGPT Soars
The launch of OpenAI’s ChatGPT created a major buzz around artificial intelligence (AI) stocks.
ChatGPT is an AI chatbot software application that uses machine-learning techniques to emulate human-written conversations. This technology is called generative AI, and it's been making an impact on myriad industries, including marketing, security, healthcare, gaming, communication, customer service and software development.
The potential behind generative AI has been the primary driver behind a major stock rally that has helped the S&P 500 (INDEXSP:.INX) and Nasdaq Composite (INDEXNASDAQ:.IXIC) reach multiple new highs since 2023.
According to Fortune Business Insights, the generative AI market is expected to grow at a compound annual growth rate of 39.6 percent between 2024 and 2032 to reach an impressive US$967.65 billion.
Although investors can’t directly take a position in privately owned OpenAI, several technology stocks offer exposure to the expected growth in generative AI technology.
Below, the Investing News Network showcases 10 generative AI stocks that stand to benefit the most from the rise in advancements and adoption of AI chatbot technologies, plus seven smaller generative AI companies that may be perfectly positioned to profit from their advancements.
Data was gathered using TradingView’s stock screener. All market cap and share price data was current as of September 2, 2025.
Biggest generative AI stocks to watch
These 10 tech giants offer investors exposure to generative AI by offering their own chatbots and generative AI products, developing the hardware and software necessary for AI and integrating AI into their product.
1. NVIDIA (NASDAQ:NVDA)
Market cap: US$4.15 trillion
Current share price: US$170.74
NVIDIA is a pioneer and global leader in graphics processing unit (GPU) technology. The company designs the specialized chips used to train AI and machine-learning models.
While it has been well known in computer and gaming spaces for decades, NVIDIA's progress in the AI sector has been the biggest growth driver in recent years. The company currently holds the title of the world’s most valuable company, coming in ahead of rivals Microsoft, Apple and Alphabet.
NVIDIA's new Blackwell GPU architecture, now in full production, delivers a significant performance leap for AI workloads compared to its predecessor. A new Blackwell Ultra system is set to be released later in 2025.
Generative AI's explosive growth is driving the market for chips designed by companies like NVIDIA and Marvell Technology (NASDAQ:MRVL), as well as for memory chips from companies like Micron Technology (NASDAQ:MU), which are another important component to training generative AI systems.
2. Microsoft (NASDAQ:MSFT)
Market cap: US$3.75 trillion
Current share price: US$505.12
The technology behemoth Microsoft has invested US$13 billion in OpenAI throughout the years, and the company's current AI solutions, Bing AI and Copilot, are based on OpenAI's technology. Microsoft has also partnered with Palantir Technologies (NASDAQ:PLTR) to provide AI tools to US defense and intelligence agencies.
More recently, Microsoft's AI branch, dubbed MAI, has branched out. In August 2025, Microsoft officially launched its first proprietary foundation model, MAI-1-preview, for its Copilot assistance, as well as a new speech model, MAI-Voice-1, designed for efficient, real-time audio processing.
3. Apple (NASDAQ:AAPL)
Market cap: US$3.41 trillion
Current share price: US$220.72
Apple has been incorporating its version of AI, Apple Intelligence, into its iPhones, MacBooks and Apple Watches. Its next major product reveal is scheduled for September 9, 2025.
The company's main goal is to deliver AI capabilities while maintaining user privacy by prioritizing on-device processing. For more complex tasks, it uses Private Cloud Compute, a secure system that runs on Apple's custom silicon chips and is designed to ensure data is not stored or made accessible to Apple.
Apple has partnered with OpenAI to integrate ChatGPT into its ecosystem. The upcoming iPhone 17 series is rumored to feature new AI-driven capabilities and enhanced integration of Apple Intelligence.
4. Alphabet (NASDAQ:GOOGL)
Market cap: US$2.56 trillion
Current share price: US$211.35
Alphabet, Google’s parent company, has played a key role in advancing generative AI. Its flagship AI model, Gemini, powers a wide range of services, with new versions continuously being rolled out. The company designs its own custom AI accelerator chips, like the TPU v5p, which are used to train large-scale language models and power its AI services.
Alphabet's subsidiary, DeepMind, focuses on AI research and development. Its AI system AlphaFold won the Nobel Prize in Chemistry in 2024 for its ability to predict the structure of proteins based on a protein's unique amino acid sequence.
AI continues to be embedded across Google's services as well. For example, AI Overviews displayed in Google Search results reach over two billion users per month as of mid-2025.
5. Amazon (NASDAQ:AMZN)
Market cap: US$2.40 trillion
Current share price: US$225.34
Amazon subsidiary and cloud-computing platform Amazon Web Services (AWS) evolved out of Amazon’s transition from an online retailer to one of the world’s largest technology companies. AWS’s wide range of services includes computing, storage, databases, networking, analytics, machine learning and AI.
AWS has many AI business tools on offer across four verticals: AI services, AI platforms, AI frameworks and AI infrastructure. Generative AI is nothing new to Amazon, as the technology forms the basis of conversational experiences with Amazon’s all-too-familiar Alexa.
Since its launch in 2023, Bedrock, a service that enhances software with generative AI capabilities, has expanded its catalog of foundation models to include OpenAI's open-weight models and Anthropic's Claude 4. At its AWS Summit in New York, the company announced Amazon Bedrock AgentCore, an innovation to help businesses rapidly deploy and scale AI agents with enterprise-grade security and tool integration.
6. Meta Platforms (NASDAQ:META)
Market cap: US$1.85 trillion
Current share price: US$735.11
Meta Platforms has expressed its commitment to continued research within the generative AI sphere with an open-source approach to its software developments. The giant behind Facebook, Instagram and WhatsApp is one of the most influential companies in tech, sharing ranks with the likes of Microsoft and Alphabet.
Meta AI, which is built with Meta Llama 3, is integrated into Meta's apps and also exists as a standalone website. The company's products use machine learning to streamline Facebook ad campaign generation and help businesses reach the right consumers. This strategy has led to Meta's ad business being a primary driver of revenue.
Meta CEO Mark Zuckerberg has maintained that increased spending on AI infrastructure is necessary to maintain its competitive position. The company has made massive infrastructure investments over the last year and has been aggressively hiring top-tier AI talent.
7. Oracle (NYSE:ORCL)
Market cap: US$632.83 billion
Current share price: US$225.30
Oracle is a tech company that's been around since the 1970s. In the early 2000s, it began buying up other software companies, and today it is one of the leading providers of cloud-based database management software. Its primary AI service, Oracle Cloud Infrastructure Generative AI, was released on January 23, 2024.
Oracle has positioned itself as a neutral platform, offering its customers a choice of top-tier models from various providers. It has recently expanded its offerings to include Google's Gemini models and has also deployed OpenAI's GPT-5 across its cloud applications and database portfolio.
Oracle maintains a longstanding partnership with NVIDIA, leveraging its hardware for large-scale AI workloads. This collaboration has culminated in the company building a zettascale supercomputer using as many as 131,072 NVIDIA Blackwell GPUs to tackle complex generative AI challenges.
8. Palantir Technologies (NASDAQ:PLTR)
Market cap: US$372.67 billion
Current share price: US$157.29
Palantir Technologies' generative AI strategy is centered on its AI Platform, a product designed to help governments and commercial enterprises integrate AI into their operations with a focus on security and human-in-the-loop control.
Rather than building models for general use, Palantir provides a platform that enables customers to leverage large language models from various providers, like OpenAI and Google, within their own private, secure networks.
9. Salesforce (NYSE:CRM)
Market cap: US$252.86 billion
Current share price: US$241.73
Salesforce is a global leader in cloud-based customer relationship management software.
In 2023, the company announced a strategy to embed generative AI across its entire product portfolio to transform how businesses interact with their customers.
In early 2025, Salesforce announced the retirement of its Einstein Copilot brand in favor of a new name, Agentforce, a fully autonomous AI agent that can handle complex, multi-step tasks across a company's sales, service and marketing operations. The company has reported that AI agents are handling up to 50 percent of customer support conversations, which has led to a significant workforce restructuring.
10. Cisco Systems (NASDAQ:CSCO)
Market cap: US$268.49 billion
Current share price: US$67.80
Multinational digital communications firm Cisco Systems is a leader in IT and communications networks.
Its strategy focuses on providing the hardware, software and security solutions enterprises need to build and deploy their own AI applications. The company has a large portfolio of multi-cloud products and applications, alongside strong relationships with Azure, AWS, NVIDIA and Google Cloud. Cisco’s AI and machine-learning offerings encompass a wide range of computing solutions for enterprises, including a focus on cybersecurity. Cisco has also brought to market new generative AI tools for IT professionals, including its own AI Assistant.
In January, the company introduced Cisco AI Defense, an end-to-end solution that protects against the misuse of AI tools, data leakage and sophisticated threats beyond the capabilities of older security systems.
Generative AI stocks to watch
The following companies have not yet reached the market capitalization of our top 10, but are each worth billions of dollars and have made some amazing achievements in generative AI technology in their own right, making them interesting prospects for investors.
In alphabetical order, they are:
- C3.ai, a company providing software as a service products to the financial and oil and gas industries. Its partnership with Alphabet allows C3.ai generative AI applications to be available on Google Cloud.
- CrowdStrike (NASDAQ:CRWD), a cybersecurity provider that monitors and analyzes Internet activity, detecting threats and blocking attacks with its generative AI-powered security analysis software, Charlotte AI. This service is available to every Falcon user and provides real-time feedback on a company’s risk landscape.
- Dell Technologies (NYSE:DELL), a supplier of crucial high-performance computing hardware required to train and run generative AI models.
- DynaTrace, a data-analysis company that provides real-time feedback on IT infrastructure for various companies using its generative AI assistant, Davis.
- IBM (NYSE:IBM), a foundational US company that develops and trains its own proprietary generative AI models, such as the Granite family of large language models. Its strategy is built on the IBM watsonx platform, which is a comprehensive suite of AI tools and services.
- Juniper Networks (NYSE:JNPR), a company that develops and markets routers, switches, network management software, network security products and software-defined networking technology. In 2021, the company introduced AI services to its networking technology and in early 2024 the company unveiled the industry's first AI-Native Networking Platform.
- SAP (NYSE:SAP), a software company out of Germany with a line of generative AI products, including its Joule AI agent, that aid companies in resource planning. The company has been collaborating with UC Berkley's Sky Computing Lab to further research how cloud technology can support AI applications.
- UiPath (NYSE:PATH), a software company with roots in Romania and headquarters in New York. UiPath designs robotic process automation software to reduce or eliminate boring or repetitive tasks like data extraction and file management, saving companies in a wide range of industries hundreds of hours thanks to its AI and generative AI software.
FAQs for generative AI
What is generative AI?
Generative AI is an emerging AI technology based on deep learning models and algorithms that can generate text, images or sounds in response to prompts given by users.
What are generative AI examples?
Some of the most notable examples of generative AI are ChatGPT, DALL-E 2, Midjourney, Stable Diffusion, Gemini, Copilot and DeepSeek.
OpenAI's DALL-E 2 is an AI system that can create realistic images and art from a description in natural language. Similar to DALL-E 2, Midjourney generates images from prompts. Stable Diffusion is a latent text-to-image diffusion model capable of generating photo-realistic images given any text input. Microsoft's Copilot is a feature of the Bing search engine that leverages the same technology as ChatGPT.
What are the hottest generative AI startups?
According to technology and business magazine e-Week, in addition to ChatGPT creator OpenAI, some of the other leading generative AI startups include Hugging Face, Synthesis AI, Jasper and Cohere.
This is an updated version of an article first published by the Investing News Network in 2023.
Don't forget to follow us @INN_Technology for real-time news updates!
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
Keep reading...Show less
04 September
RemSense Eyes More Strategic Partnerships for Global Growth
RemSense (ASX:REM) is looking to secure more strategic partnerships as the company eyes global expansion, according to CEO and Managing Director Warren Cook.
“We have a strong pipeline of services to deliver to our existing clients that's going to take us right up through to the end of the year and into the early new year. For our global growth, we see partnerships as a critical part of our strategy to give us scale and capacity to grow throughout other parts of the region,” Cook said in an interview with the Investing News Network.
RemSense’s 3D visualisation technology — called virtualplant — is used by some major companies, including Woodside Energy Group (ASX:WDS,NYSE:WDS) and Chevron (NYSE:CVX).
“(We’re) just growing globally, with projects in the US, Bangladesh and now our more recent one in Norway, and Newmont (TSX:NGT,NYSE:NEM,ASX:NEM), one of the largest gold companies in the world,” Cook said.
“Those are just the three tier ones, and then we've got other tier two, tier three customers who are very loyal to us, like Triangle Energy (ASX:TEG). We delivered services to the likes of BHP (ASX:BHP,NYSE:BHP,LSE:BHP), Rio Tinto (ASX:RIO,NYSE:RIO,LSE:RIO). So we're really putting a lot of effort into broadening our customer base, both in in tiers and globally.”
Watch the full interview with Warren Cook, CEO and managing director of RemSense, above.
Keep reading...Show less
Latest News
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00